SciELO - Scientific Electronic Library Online

 
vol.64 número4Diagnóstico citológico de lesiones focales intra-abdominales en pacientes que acuden al servicio de gastroenterología del Hospital Central universitario “Antonio María Pineda”: Barquisimeto-Estado LaraCambios mínimos esofágicos: ¿desapercibidos en la video endoscopia de pacientes con enfermedad de reflujo gastroesofágico no erosiva? índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Gen

versão impressa ISSN 0016-3503versão On-line ISSN 2477-975X

Resumo

NUCETTE, Ana et al. Hipertensión portal en niños: historia natural, evolución, tratamiento y pronóstico. Gen [online]. 2010, vol.64, n.4, pp.323-329. ISSN 0016-3503.

Portal Hypertension (PHT) in children is hard to handle with as a result of multiple etiologies and because of using non standardized treatments. Purpose: Reporting the PHT’s natural history in children assisted in the Unit, assessing the evolution and impact of the treatment in the prognosis. Methods and Patients: 27 patients assessed between 1999 and 2009. The following was recorded: etiology, clinic, laboratory, Eco-Doppler, endoscopic classification of esophageal, gastric and fundic varices, Child-Pugh, and endoscopic therapy. Results: 18/27 (66.66%), Portal Cavernomatosis; 3/27 (11.11%), Secondary Liver Cirrhosis to Autoimmune Hepatitis; 3/27 (11.11%), Congenital Hepatic Fibrosis; 2/27 (7.40%), Familial Intrahepatic Cholestasis; and 1/27 (3.70%), Budd-Chiari Syndrome; average age: 4.6 ± 4.47. First time with upper digestive hemorrhage: 17/27 (62.96%). Grade III Esophageal Varices, 13/27 (48.14%); and Grade IV: 4/27 (14.81%); Severe Hypertensive Gastropathy: 5/27 (18.51%); Type-II Gastro-esophageal Varices: 9/27 (33.33%). Primary prophylaxis by Propanolol: 9/27 (33.33%); and endoscopic ligature plus Propanolol: 1/27 (3.70%). Secondary prophylaxis: 17/27 (62.96%); with endoscopic ligature: 47.05%; Sclerotherapy: 35.29%; and ligature plus sclerosis: 17.64%. Usage of somatostatin: 2/17 (11.76%); and failure in controlling post-treatment hemorrhage: 1/17 (5.88%). Child-Pugh B: 4/27 (14.81%); and Child-Pugh C: 4/27 (14.81%). Post-Treatment: eradication of esophageal varices by endoscopic ligatures in 50% vs. 35.71% with sclerotherapy (p< 0.05), a 2 ± 1.41 average of sessions vs. 3.4 ± 1.78, respectively. Rebleeding in 2/17 (11.76%). Children with cirrhosis, with Child-Pugh B and C, compensated the hepatic disturbance with endoscopic therapy. A 5.3-year follow-up: 1/27 (3.70%) morbidity; one liver transplantation; 2 portal-cava derivation, and 3 in the wait list. Conclusion: The prescribed primary or secondary prophylaxis diminished the risk of varicose hemorrhage with few complications, and improved the patients’ prognosis.

Palavras-chave : portal hypertension; natural history; esophageal varices; sclerosis; ligature.

        · resumo em Espanhol     · texto em Espanhol

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons